FindTrial
Sign In

SAFER TREATMENT OPTION FOR TENDON INFLAMMATION OF THE WRIST

A STUDY ON THE ACCURACY OF ULTRASOUND GUIDED AUTOLOGOUS PLATELET RICH PLASMA INJECTION IN DE QUERVAINS TENOSYNOVITIS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/026179
Enrollment
46
Registered
2020-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R298- Other symptoms and signs involvingthe nervous and musculoskeletal systems Health Condition 2: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Intervention1: Autologous platelet rich plasma injection in de Quervains tenosynovitis: Autologous platelet rich plasma injection will be used to treat patients presenting with symptoms and have diagn

Sponsors

Ashish Mathew
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Patients (male or female) in age group of 18-65 years ii. A documented history of pain over the radial aspect of the wrist, aggravated by excessive use of the thumb, iii. A documented positive Finkelsteinâ??s test in the patientâ??s medical record. iv. A documented physicianâ??s diagnosis of de Quervainâ??s tenosynovitis, v. Patients who will give consent for treatment with autologous platelet rich plasma injection under ultrasound guidance and without ultrasound guidance as per our protocol.

Exclusion criteria

Exclusion criteria: i. Patients with corticosteroid injection at treatment site within 1 month and/or surgery at the same anatomical location, and ii. Patient with pathologies in the region like:(Skin lesions, cervical radiculopathy,lateral epicondylitis of the humerus, rotator cuff injuries, previous fractures or direct trauma)

Design outcomes

Primary

MeasureTime frame
DASH scoring of the patients will be recorded and improvements in the scoring will be recorded after the procedureTimepoint: DASH scoring of the patients will be recorded before and after the procedure . Improvements in the scoring will be recorded after the procedure at 2 weeks and 2 months of the procedure.—

Secondary

MeasureTime frame
Patients with improved DASH scoring may avoid a possible surgery for the treatment of the condition.Timepoint: 1 year—

Countries

India

Contacts

Public ContactASHISH MATHEW

Father Muller Medical College and Research Institute , Mangalore

dredwardortho@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026